Integracin A is primarily used in research settings for its ability to modulate integrin-mediated cellular processes. It shows promise in studies related to cell adhesion, migration, and signaling, which are critical in understanding cancer metastasis and inflammatory diseases. Due to its specific interaction with certain integrin receptors, it serves as a valuable tool in probing pathways involved in tumor progression and immune cell activation. It is also being explored for potential applications in developing targeted therapies that inhibit abnormal cell attachment and invasion without disrupting normal tissue function.